[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

China Hypertension Drugs Market Research Report 2018

March 2018 | 95 pages | ID: C017B45C2F1EN
QYResearch

US$ 3,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Hypertension Drugs market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Hypertension Drugs development status and future trend in China, focuses on top players in China, also splits Hypertension Drugs by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
  • Novartis
  • Daiichi Sankyo
  • Actelion Pharmaceuticals
  • Boehringer Ingelheim
  • Sanofi
  • Pfizer
  • Actelion Pharmaceuticals
  • Bayer
  • Johnson & Johnson
  • Merck
Geographically, this report splits the China market into six regions,
  • South China
  • East China
  • Southwest China
  • Northeast China
  • North China
  • Central China
  • Northwest China
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
  • Systemic hypertension drugs
  • Pulmonary hypertension drugs
On the basis of the end users/application, this report covers
  • Drugstore
  • Hospital
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
China Hypertension Drugs Market Research Report 2018

1 HYPERTENSION DRUGS OVERVIEW

1.1 Product Overview and Scope of Hypertension Drugs
1.2 Classification of Hypertension Drugs by Product Category
  1.2.1 China Hypertension Drugs Sales (K Units) Comparison by Type (2013-2025)
  1.2.2 China Hypertension Drugs Sales (K Units) Market Share by Type in 2017
  1.2.3 Systemic hypertension drugs
  1.2.4 Pulmonary hypertension drugs
1.3 China Hypertension Drugs Market by Application/End Users
  1.3.1 China Hypertension Drugs Sales (K Units) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Drugstore
  1.3.3 Hospital
  1.3.4 Others
1.4 China Hypertension Drugs Market by Region
  1.4.1 China Hypertension Drugs Market Size (Million USD) Comparison by Region (2013-2025)
  1.4.2 South China Hypertension Drugs Status and Prospect (2013-2025)
  1.4.3 East China Hypertension Drugs Status and Prospect (2013-2025)
  1.4.4 Southwest China Hypertension Drugs Status and Prospect (2013-2025)
  1.4.5 Northeast China Hypertension Drugs Status and Prospect (2013-2025)
  1.4.6 North China Hypertension Drugs Status and Prospect (2013-2025)
  1.4.7 Central China Hypertension Drugs Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Hypertension Drugs (2013-2025)
  1.5.1 China Hypertension Drugs Sales (K Units) and Growth Rate (%)(2013-2025)
  1.5.2 China Hypertension Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 CHINA HYPERTENSION DRUGS MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Hypertension Drugs Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Hypertension Drugs Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Hypertension Drugs Average Price (USD/Unit) by Players/Manufacturers (2013-2018)
2.4 China Hypertension Drugs Market Competitive Situation and Trends
  2.4.1 China Hypertension Drugs Market Concentration Rate
  2.4.2 China Hypertension Drugs Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Hypertension Drugs Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA HYPERTENSION DRUGS SALES AND REVENUE BY REGION (2013-2018)

3.1 China Hypertension Drugs Sales (K Units) and Market Share by Region (2013-2018)
3.2 China Hypertension Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Hypertension Drugs Price (USD/Unit) by Regions (2013-2018)

4 CHINA HYPERTENSION DRUGS SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2013-2018)

4.1 China Hypertension Drugs Sales (K Units) and Market Share by Type/ Product Category (2013-2018)
4.2 China Hypertension Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Hypertension Drugs Price (USD/Unit) by Type (2013-2018)
4.4 China Hypertension Drugs Sales Growth Rate (%) by Type (2013-2018)

5 CHINA HYPERTENSION DRUGS SALES BY APPLICATION (2013-2018)

5.1 China Hypertension Drugs Sales (K Units) and Market Share by Application (2013-2018)
5.2 China Hypertension Drugs Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 CHINA HYPERTENSION DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Hypertension Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Daiichi Sankyo
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Hypertension Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Daiichi Sankyo Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Actelion Pharmaceuticals
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Hypertension Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Actelion Pharmaceuticals Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Boehringer Ingelheim
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Hypertension Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Boehringer Ingelheim Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Sanofi
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Hypertension Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Pfizer
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Hypertension Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Pfizer Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Actelion Pharmaceuticals
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Hypertension Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Actelion Pharmaceuticals Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Bayer
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Hypertension Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bayer Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Johnson & Johnson
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Hypertension Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Johnson & Johnson Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Merck
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Hypertension Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Merck Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.10.4 Main Business/Business Overview

7 HYPERTENSION DRUGS MANUFACTURING COST ANALYSIS

7.1 Hypertension Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Hypertension Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Hypertension Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Hypertension Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA HYPERTENSION DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2025)

11.1 China Hypertension Drugs Sales (K Units), Revenue (Million USD) Forecast (2018-2025)
11.2 China Hypertension Drugs Sales (K Units) Forecast by Type (2018-2025)
11.3 China Hypertension Drugs Sales (K Units) Forecast by Application (2018-2025)
11.4 China Hypertension Drugs Sales (K Units) Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Hypertension Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Hypertension Drugs Sales (K Units) by Application (2013-2025)
Figure Product Picture of Hypertension Drugs
Table China Hypertension Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Hypertension Drugs Sales Volume Market Share by Types in 2017
Figure Systemic hypertension drugs Product Picture
Figure Pulmonary hypertension drugs Product Picture
Figure China Hypertension Drugs Sales (K Units) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Hypertension Drugs by Application in 2017
Figure Drugstore Examples
Table Key Downstream Customer in Drugstore
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Hypertension Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Hypertension Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Hypertension Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Hypertension Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Hypertension Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Hypertension Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Hypertension Drugs Sales (K Units) and Growth Rate (%)(2013-2025)
Figure China Hypertension Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Hypertension Drugs Sales of Key Players/Manufacturers (2013-2018)
Table China Hypertension Drugs Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Hypertension Drugs Sales Share (%) by Players/Manufacturers
Figure 2017 China Hypertension Drugs Sales Share (%) by Players/Manufacturers
Table China Hypertension Drugs Revenue by Players/Manufacturers (2013-2018)
Table China Hypertension Drugs Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Hypertension Drugs Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Hypertension Drugs Revenue Market Share (%) by Players/Manufacturers
Table China Market Hypertension Drugs Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Hypertension Drugs Average Price of Key Players/Manufacturers in 2017
Figure China Hypertension Drugs Market Share of Top 3 Players/Manufacturers
Figure China Hypertension Drugs Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Hypertension Drugs Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Hypertension Drugs Product Category
Table China Hypertension Drugs Sales (K Units) by Regions (2013-2018)
Table China Hypertension Drugs Sales Share (%) by Regions (2013-2018)
Figure China Hypertension Drugs Sales Share (%) by Regions (2013-2018)
Figure China Hypertension Drugs Sales Market Share (%) by Regions in 2017
Table China Hypertension Drugs Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Hypertension Drugs Revenue Market Share (%) by Regions (2013-2018)
Figure China Hypertension Drugs Revenue Market Share (%) by Regions (2013-2018)
Figure China Hypertension Drugs Revenue Market Share (%) by Regions in 2017
Table China Hypertension Drugs Price (USD/Unit) by Regions (2013-2018)
Table China Hypertension Drugs Sales (K Units) by Type (2013-2018)
Table China Hypertension Drugs Sales Share (%) by Type (2013-2018)
Figure China Hypertension Drugs Sales Share (%) by Type (2013-2018)
Figure China Hypertension Drugs Sales Market Share (%) by Type in 2017
Table China Hypertension Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Hypertension Drugs Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Hypertension Drugs by Type (2013-2018)
Figure Revenue Market Share of Hypertension Drugs by Type in 2017
Table China Hypertension Drugs Price (USD/Unit) by Types (2013-2018)
Figure China Hypertension Drugs Sales Growth Rate (%) by Type (2013-2018)
Table China Hypertension Drugs Sales (K Units) by Applications (2013-2018)
Table China Hypertension Drugs Sales Market Share (%) by Applications (2013-2018)
Figure China Hypertension Drugs Sales Market Share (%) by Application (2013-2018)
Figure China Hypertension Drugs Sales Market Share (%) by Application in 2017
Table China Hypertension Drugs Sales Growth Rate (%) by Application (2013-2018)
Figure China Hypertension Drugs Sales Growth Rate (%) by Application (2013-2018)
Table Novartis Hypertension Drugs Basic Information List
Table Novartis Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Novartis Hypertension Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Novartis Hypertension Drugs Sales Market Share (%) in China (2013-2018)
Figure Novartis Hypertension Drugs Revenue Market Share (%) in China (2013-2018)
Table Daiichi Sankyo Hypertension Drugs Basic Information List
Table Daiichi Sankyo Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Daiichi Sankyo Hypertension Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Daiichi Sankyo Hypertension Drugs Sales Market Share (%) in China (2013-2018)
Figure Daiichi Sankyo Hypertension Drugs Revenue Market Share (%) in China (2013-2018)
Table Actelion Pharmaceuticals Hypertension Drugs Basic Information List
Table Actelion Pharmaceuticals Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Actelion Pharmaceuticals Hypertension Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Actelion Pharmaceuticals Hypertension Drugs Sales Market Share (%) in China (2013-2018)
Figure Actelion Pharmaceuticals Hypertension Drugs Revenue Market Share (%) in China (2013-2018)
Table Boehringer Ingelheim Hypertension Drugs Basic Information List
Table Boehringer Ingelheim Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Boehringer Ingelheim Hypertension Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Boehringer Ingelheim Hypertension Drugs Sales Market Share (%) in China (2013-2018)
Figure Boehringer Ingelheim Hypertension Drugs Revenue Market Share (%) in China (2013-2018)
Table Sanofi Hypertension Drugs Basic Information List
Table Sanofi Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Sanofi Hypertension Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Sanofi Hypertension Drugs Sales Market Share (%) in China (2013-2018)
Figure Sanofi Hypertension Drugs Revenue Market Share (%) in China (2013-2018)
Table Pfizer Hypertension Drugs Basic Information List
Table Pfizer Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Pfizer Hypertension Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Pfizer Hypertension Drugs Sales Market Share (%) in China (2013-2018)
Figure Pfizer Hypertension Drugs Revenue Market Share (%) in China (2013-2018)
Table Actelion Pharmaceuticals Hypertension Drugs Basic Information List
Table Actelion Pharmaceuticals Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Actelion Pharmaceuticals Hypertension Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Actelion Pharmaceuticals Hypertension Drugs Sales Market Share (%) in China (2013-2018)
Figure Actelion Pharmaceuticals Hypertension Drugs Revenue Market Share (%) in China (2013-2018)
Table Bayer Hypertension Drugs Basic Information List
Table Bayer Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Bayer Hypertension Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Bayer Hypertension Drugs Sales Market Share (%) in China (2013-2018)
Figure Bayer Hypertension Drugs Revenue Market Share (%) in China (2013-2018)
Table Johnson & Johnson Hypertension Drugs Basic Information List
Table Johnson & Johnson Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Johnson & Johnson Hypertension Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Johnson & Johnson Hypertension Drugs Sales Market Share (%) in China (2013-2018)
Figure Johnson & Johnson Hypertension Drugs Revenue Market Share (%) in China (2013-2018)
Table Merck Hypertension Drugs Basic Information List
Table Merck Hypertension Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Merck Hypertension Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Merck Hypertension Drugs Sales Market Share (%) in China (2013-2018)
Figure Merck Hypertension Drugs Revenue Market Share (%) in China (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hypertension Drugs
Figure Manufacturing Process Analysis of Hypertension Drugs
Figure Hypertension Drugs Industrial Chain Analysis
Table Raw Materials Sources of Hypertension Drugs Major Players/Manufacturers in 2017
Table Major Buyers of Hypertension Drugs
Table Distributors/Traders List
Figure China Hypertension Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure China Hypertension Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Hypertension Drugs Price (USD/Unit) Trend Forecast (2018-2025)
Table China Hypertension Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure China Hypertension Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure China Hypertension Drugs Sales Volume Market Share Forecast by Type in 2025
Table China Hypertension Drugs Sales (K Units) Forecast by Application (2018-2025)
Figure China Hypertension Drugs Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Hypertension Drugs Sales Volume Market Share Forecast by Application in 2025
Table China Hypertension Drugs Sales (K Units) Forecast by Regions (2018-2025)
Table China Hypertension Drugs Sales Volume Share Forecast by Regions (2018-2025)
Figure China Hypertension Drugs Sales Volume Share Forecast by Regions (2018-2025)
Figure China Hypertension Drugs Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories